Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday. LFCR has been the subject of several other research reports. Barrington Research increased their price objective on shares of Lifecore […]
Lifecore Biomedical (NASDAQ:LFCR) Stock Rating Upgraded by Wall Street Zen
Source: Americanbankingnews
Read Full Story →
